Your shopping cart is currently empty

Dehydro aripiprazole is the primary, active metabolite of aripiprazole, an atypical antipsychotic. The metabolite is produced from the parent compound by the actions of cytochrome P450 (CYP) isoforms CYP3A4 and CYP2D6. Dehydro aripiprazole has similar pharmacological properties to aripiprazole.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $352 | 35 days | 35 days | |
| 5 mg | $1,220 | 35 days | 35 days | |
| 10 mg | $2,260 | 35 days | 35 days |
| Description | Dehydro aripiprazole is the primary, active metabolite of aripiprazole, an atypical antipsychotic. The metabolite is produced from the parent compound by the actions of cytochrome P450 (CYP) isoforms CYP3A4 and CYP2D6. Dehydro aripiprazole has similar pharmacological properties to aripiprazole. |
| Targets&IC50 | 5-HT1A receptor:4.2 nM (Ki) |
| Molecular Weight | 482.83 |
| Formula | C23H26Cl3N3O2 |
| Cas No. | 1008531-60-9 |
| Smiles | Cl.O=C1C=CC=2C=CC(OCCCCN3CCN(C=4C=CC=C(Cl)C4Cl)CC3)=CC2N1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMF: 25 mg/mL (51.78 mM), Sonication is recommended. DMF:PBS (pH 7.2)(1:3): 0.25 mg/mL (0.52 mM), Sonication is recommended. DMSO: 20 mg/mL (41.42 mM), Sonication is recommended. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.